Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microfluidic Application Centre Appoints Gillian Davis to Strategic Commercial Role

Published: Monday, September 17, 2007
Last Updated: Monday, September 17, 2007
Bookmark and Share
Dr. Gillian will be instrumental in securing new business opportunities and managing customer relations at Dolomite microfluidic capabilities and services.

Dolomite has appointed Dr Gillian Davis to the position of Commercial Director. In this strategic role, Gillian will be instrumental in securing new business opportunities and managing customer relations for Dolomite’s microfluidic capabilities and services.

‘This is an exciting development for us,’ said Mark Gilligan, Managing Director of Dolomite, ‘and reflects the increasing level of interest we are experiencing around the world from customers interested in working with us to bring their microfluidic concepts to market.’

‘I am delighted to welcome Gillian on board, she brings to the company not only a strong background in business development, but also extensive experience of working at the cutting edge of a diverse range of technical disciplines, including materials processing, liquid crystal displays and fibre optic communications. Having people on board with a broad technical background is particularly important to a company, such as Dolomite, which offers a service with an extremely wide application base, including environmental monitoring, clinical diagnostics, drug discovery, nuclear fuels reprocessing and forensic science.’

Dolomite’s key strength lies in being able to offer a complete service to customers from problem conceptualisation and feasibility testing through to full instrument design and development.

The Company says, Gillian’s appointment is just the beginning of Dolomite’s efforts to meet the demand from customers for a partner they can work with to bring their concepts for microfluidic products to market.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Enter the Dolomite and Lab on a Chip Productizing Science® Competition 2015 Now!
Don’t miss the chance to drive microfluidics innovation forwards.
Thursday, April 23, 2015
Dolomite and Lab on a Chip Launch Productizing Science® Competition 2015
Competition offers the opportunity to take advantage of Dolomite’s invaluable commercial expertise and in-depth understanding of the international microfluidics market.
Wednesday, October 08, 2014
Dolomite Announces Exclusive Agreement with Fluika
Agreement for the sale of compact microfluidic pressure and vacuum pumps for pneumatic control systems in microfluidics, chemistry and mechatronics.
Tuesday, August 05, 2014
Dolomite Announces 2013 Productizing Science® Competition Winner
Fully automated DNA lab-on-a-chip microfluidic system wins Dolomite’s competition.
Tuesday, June 10, 2014
Dolomite Microfluidics, Sphere Fluidics Partner
Agreement will see companies deliver world leading droplet based technology.
Thursday, May 01, 2014
R&D Consortium to Develop Optical Sorting of Stem Cells
Dolomite is collaborating with European technology leaders over a two year publicly funded consortium.
Tuesday, December 17, 2013
Epigem and Dolomite Join Forces
Both Companies announces collaboration in the design and manufacture of microfluidic devices.
Wednesday, March 13, 2013
Dolomite Celebrates a Successful 2012
Microfluidics company Dolomite has reported an exceptional 20% year-on-year growth in 2012.
Tuesday, February 12, 2013
Dolomite Announces Microdroplet IP License Arrangements with JST
Dolomite offers a wide range of Droplet-forming devices.
Friday, August 24, 2012
Dolomite’s Launches Productizing Science™ Competition
New competition offering the chance to productize scientific discoveries.
Monday, June 18, 2012
Dolomite Joins Forces with LioniX B.V.
Companies join forces in the areas of designing, developing and fabricating microfluidic devices and systems.
Thursday, May 03, 2012
Dolomite and GigaGen Collaborate to Develop Novel Droplet Merging Technology
Development of a novel Droplet Merger Chip for massively parallel single cell genetic analysis.
Friday, February 17, 2012
Microfluidics Specialist Dolomite Signs Collaboration Agreement with Sphere Fluidics
Sphere Fluidics offers extensive expertise in miniaturized Discovery Systems and Services based on microfluidics and picodroplets.
Wednesday, May 11, 2011
Dolomite and Emerald BioSystems collaborate to produce award winning novel protein crystallography instrument
Dolomite is delighted to announce its collaboration with Emerald BioSystems in the development of the Microcapillary Protein Crystallization System (MPCS) Plug Maker™.
Tuesday, March 16, 2010
Pushing the Boundaries of Microfluidics
New Expert Advisory Group is formed to advance Dolomite’s growing application areas.
Thursday, November 09, 2006
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!